AGA Nanotech have officially opened their state of the art research facility in Halifax. Based in Greetland, the Fellows Research Facility is the home of ground-breaking antimicrobial resistance (AMR) research, committed to finding a workable solution to the global health crisis of antibiotic resistance.
Leeds University Vice-Chancellor and former Chief Executive of the NHS, Alan Langlands, carried out the opening of the vital Halifax facility in a joint ceremony.
The £4m lab will be staffed with up to 20 qualified professionals conducting high-tech, valuable research in all aspects of microbiology, infection control and analytical chemistry.
The research facility was named after GAMA’s Research Director, Adrian Fellows – whose local Halifax connection inspired the Greetland location of the lab.
The Fellows Research Facility, focuses specifically on researching and developing products to combat the public health fight against antibiotic resistant infection. The West-Yorkshire based lab has been welcomed by local figures, thanks to the positive impact the facility has had on the resident science cluster.
Local MP Holly Lynch, praised the investment in Halifax and warmly welcomed the expert healthcare product distributors to her constituency.
Dr Guy Braverman, MD and Co-founder of GAMA Healthcare, the parent company of AGA Nanotech, said:
“This is the latest development in the long story of GAMA’s progression from a new company with a handful of employees to the point we are at now, where we have an international reach and multiple facilities in the UK. All credit and thanks goes to those who have worked so hard to ensure that this ambitious project has become a reality.”
Read more about the facility's launch on Halifax Courier and Yorkshire Insider.
If you have an event or news which you would like assistance with promoting to local, national and trade press, get in touch with Medilink NOE's PR and Communications team on 0114 232 9292